| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |